Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

Approximately 150 subjects will be enrolled, receiving either the therapy or a placebo daily for a 52-week treatment period.

Researchers have uncovered another piece of the Parkinson’s disease puzzle, identifying that particular immune cells are ...

Police say two security guards at a church outside of Detroit stopped a potential mass shooting Sunday morning. One person ...

A large longitudinal study found that pesticide exposure and caffeinated soda intake were linked to more severe motor ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

Researchers in East London found that South Asian and Black Parkinson’s disease patients experience more severe motor and ...

When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle weakness, assuming that could be a sig ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Differences in the chemicals people's bodies produce - which some people can even smell - may help detect the disease much ...